Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dutasteride versus finasteride for male androgenetic alopecia
TCTR20221106001Phase 3Completed
- Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dutasteride, finasteride in androgenetic alopecia (AGA), sponsored by Faculty of Medicine, Srinakharinwirot University. Started Feb 2022; status: completed.
02
Drugs
dutasteridefinasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20221106001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221106001.